Cincinnati, OH, United States of America

Joo-Youp Lee

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: University of Cincinnati. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joo-Youp Lee. Retrieved from https://idiyas.com/inventor/joo-youp-lee-ertav2z0

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Joo-Youp Lee: Innovator in Prodrug Development

Introduction

Joo-Youp Lee is a prominent inventor based in Cincinnati, OH (US). He has made significant contributions to the field of drug development, particularly in the area of prodrugs designed for sustained and controlled release.

Latest Patents

Joo-Youp Lee holds a patent for a "Method of making prodrug for sustained and controlled release." This innovative prodrug utilizes a unique modified oxalate linker conjugated to 4-aminophenol. The design enhances the reaction kinetics for intracellular reactive oxygen species (ROS) within tumor tissues while maintaining the stability of the modified oxalate backbone with an amide bond under very low ROS levels. He has 1 patent to his name.

Career Highlights

Joo-Youp Lee is affiliated with the University of Cincinnati, where he continues to advance research in pharmaceutical sciences. His work focuses on developing novel therapeutic strategies that can improve patient outcomes in cancer treatment.

Collaborations

He has collaborated with notable colleagues, including Edward J Merino and Vishnu Sriram, to further enhance the impact of his research and innovations.

Conclusion

Joo-Youp Lee's contributions to the field of prodrug development exemplify the importance of innovative approaches in medicine. His work not only advances scientific knowledge but also holds the potential to improve therapeutic options for patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…